Immunogenicity and protective efficacy of three DNA vaccines encoding pre-erythrocytic- and erythrocytic-stage antigens of Plasmodium cynomolgi in rhesus monkeys

被引:9
作者
Bhardwaj, D
Hora, B
Singh, N
Puri, SK
Lalitha, P
Rupa, P
Chauhan, VS [1 ]
机构
[1] Int Ctr Genet Engn & Biotechnol, Malaria Res Grp, New Delhi 110067, India
[2] Cent Drug Res Inst, Div Parasitol, Lucknow 242001, Uttar Pradesh, India
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2002年 / 34卷 / 01期
关键词
DNA vaccine; malaria; Plasmodium cynomolgi; sporozoite;
D O I
10.1111/j.1574-695X.2002.tb00600.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although several malaria vaccine candidate antigens have been identified, the most suitable methods for their delivery are still being investigated. In this regard, direct immunization with DNA encoding these vaccine target antigens is an attractive alternative. Here, we have investigated the immune responses to DNA immunization with three major vaccine target antigens: the apical membrane antigen-1 and the 19-kDa C-terminal fragment of merozoite surface protein-1 from the erythrocytic stage, and the thrombospondin-related adhesive protein from the pre-erythrocytic stage of Plasmodium cynomolgi in rhesus monkeys. Antigen-specific antibodies were developed in all the immunized monkeys and peripheral blood mononuclear cells from all immunized monkeys proliferated to different extents upon in vitro stimulation with the corresponding recombinant proteins. The immunized monkeys were challenged with P. cynomolgi sporozoites. All of the immunized animals developed infection but although there was no significant difference between the control and vaccinated animals in terms of pre-patent period, total duration of patency and primary peak parasitemia, the vaccinated animals had significantly lower secondary peak parasitemia than the control animals. (C) 2002 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:33 / 43
页数:11
相关论文
共 34 条
[11]   DNA vaccines: Immunology, application, and optimization [J].
Gurunathan, S ;
Klinman, DM ;
Seder, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :927-974
[12]  
Kang Y, 1998, J IMMUNOL, V161, P4211
[13]   Immunogenicity of recombinant fragments of Plasmodium falciparum acidic basic repeat antigen produced in Escherichia coli [J].
Kushwaha, A ;
Rao, PPL ;
Suresh, RP ;
Chauhan, VS .
PARASITE IMMUNOLOGY, 2001, 23 (08) :435-444
[14]   PLASMODIUM-VIVAX MEROZOITE SURFACE PROTEIN-1 C-TERMINAL RECOMBINANT PROTEINS IN BACULOVIRUS [J].
LONGACRE, S ;
MENDIS, KN ;
DAVID, PH .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1994, 64 (02) :191-205
[15]   An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi [J].
Luke, CJ ;
Carner, K ;
Liang, XW ;
Barbour, AG .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (01) :91-97
[16]  
MENDIS KN, 1995, CEYLON MED J SCI, V38, P31
[17]   Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria [J].
Perera, KLRL ;
Handunnetti, SM ;
Holm, I ;
Longacre, S ;
Mendis, K .
INFECTION AND IMMUNITY, 1998, 66 (04) :1500-1506
[18]   Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus [J].
Prince, AM ;
Whalen, R ;
Brotman, B .
VACCINE, 1997, 15 (08) :916-919
[19]   Azithromycin: Antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys [J].
Puri, SK ;
Singh, N .
EXPERIMENTAL PARASITOLOGY, 2000, 94 (01) :8-14
[20]  
RICKMAN KH, 1990, B WHO S, V68, P13